BiotechTube

AndroGel® + Placebo

ApprovedCompleted
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism, Cardiovascular Diseases

Trial Timeline

May 3, 2018 → Jan 19, 2023

NCT ID
NCT03518034

About AndroGel® + Placebo

AndroGel® + Placebo is a approved stage product being developed by AbbVie for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT03518034. Target conditions include Hypogonadism, Cardiovascular Diseases.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT03518034ApprovedCompleted

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Topical Testosterone SolutionEli LillyApproved
85
Testosterone Solution + Placebo SolutionEli LillyPhase 3
77
Testosterone MD-LotionEli LillyPhase 2
52
Testosterone MD-LotionEli LillyPhase 3
77
Testosterone MD-LotionEli LillyPhase 3
77
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
33
ABT-SLV176AbbViePhase 3
77
AndroGel 1.62%AbbVieApproved
85
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
77
Oral testosterone undecanoate (Andriol) + PlaceboMerckPhase 2
52
Reference: Follitropin alfa + ZoladexMerckPhase 1
33
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
52
Testosterone Enanthate + FinasterideMerckPhase 2
52
Testim 1% (testosterone gel) + PlaceboMerckPhase 2
52
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
52
Test formulation + Reference formulationPfizerPhase 1
32
Testosterone ProductBayerPre-clinical
20
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
74
Testosterone Undeconate (Nebido-R, BAY86-5037)BayerPre-clinical
20
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
82

Other Products from AbbVie

Pancrelipase + PancrelipaseApproved
85
CREONApproved
85
Venetoclax + AzacitidineApproved
85
Oxybutynin + PlaceboApproved
85
Glecaprevir-pibrentasvirApproved
85